scispace - formally typeset
J

Jacques Ferlay

Researcher at International Agency for Research on Cancer

Publications -  145
Citations -  276378

Jacques Ferlay is an academic researcher from International Agency for Research on Cancer. The author has contributed to research in topics: Cancer & Population. The author has an hindex of 69, co-authored 129 publications receiving 211074 citations.

Papers
More filters
Journal ArticleDOI

International uveal melanoma incidence trends in view of a decreasing proportion of morphological verification

TL;DR: Uveal melanoma incidence rates in the United States SEER Caucasian population is due mainly to an incidence decline in the early registration period (from 1974-76 to 1986-88), and the data from France and Italy suggest a recent increase in incidence.
Journal ArticleDOI

Cancer in Iran 2008 to 2025: Recent incidence trends and short-term predictions of the future burden.

Gholamreza Roshandel, +80 more
TL;DR: In this paper, the authors developed a method for approximating population-based incidence from the pathology-based data series available nationally for the years 2008 to 2013, and augmented this with data from the Iranian National Population-based Cancer Registry (INPCR), and fitted timelinear age-period models to the recent incidence trends to quantify the future cancer incidence burden to the year 2025, delineating the contribution of changes due to risk and those due to demographic change.
Journal ArticleDOI

Global demand for cancer surgery and an estimate of the optimal surgical and anaesthesia workforce between 2018 and 2040: a population-based modelling study

TL;DR: In this article, the authors estimated the global demand for cancer surgery and the requirements for an optimal surgical and anaesthesia workforce, using benchmarks based on clinical guidelines, using GLOBOCAN 2018 data and then aggregated to obtain the estimated number of surgical procedures required globally.
Journal ArticleDOI

Exploring variations in ovarian cancer survival by age and stage (ICBP SurvMark-2): A population-based study

TL;DR: International variations in ovarian cancer survival by stage exist with the largest differences observed in the oldest age group with advanced disease, and this finding endorses further research investigating international differences in access to and quality of treatment, and prevalence of comorbid conditions particularly in older women withAdvanced disease.
Journal ArticleDOI

The recent decline in mortality from Hodgkin lymphomas in central and eastern Europe

TL;DR: The present work confirms the persistent declines in HL mortality in western European countries, and shows favorable patterns over more recent calendar years in central/eastern ones, where rates are still at levels observed in western Europe in the early 1990s.